# Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

> **NCT01183065** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 13 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Pralatrexate With Vitamin B12 and Folic Acid

## Key facts

- **NCT ID:** NCT01183065
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2015-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01183065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01183065, "Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01183065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*